A Study to Assess the Effect of SB 659032 on Platelet Function

NCT01750827 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Atherosclerosis

Interventions

DRUG: SB659032

Sponsor

GlaxoSmithKline